US Broker Ratings

Humana Inc. (HUM) Stock Analysis: Exploring a 19.45% Potential Upside in the Healthcare Sector

Humana Inc. (HUM), a key player in the healthcare plans industry, is gaining the attention of investors with its compelling growth prospects and a potential upside of 19.45%. With a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Unveiling a 11.16% Upside Potential for Investors

For investors eyeing opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents a compelling case. The Dutch multinational, renowned for its advanced medical devices, has been a significant..

Cytokinetics, Incorporated (CYTK) Stock Analysis: A Biotech Powerhouse with 33% Potential Upside

Cytokinetics, Incorporated (NASDAQ: CYTK) is increasingly capturing the attention of investors in the biotechnology sector. With a market capitalization of $8.31 billion, this late-stage biopharmaceutical company is exploring new frontiers..

Madrigal Pharmaceuticals, Inc. (MDGL): Investor Outlook Reveals 53% Potential Upside in Biotechnology

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is emerging as a notable player in the biotechnology sector, capturing investor attention with its focus on cutting-edge therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). With..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Exploring a 10.19% Potential Upside in the Biotech Frontier

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leading player in the biotechnology sector, is garnering attention for its innovative RNA-targeted therapies. With a market capitalization of $13.47 billion, this U.S.-based company..

DaVita Inc. (DVA) Stock Analysis: Navigating the Healthcare Sector with a Strong Return on Equity

DaVita Inc. (NYSE: DVA), a prominent player in the healthcare sector, specializes in providing kidney dialysis services, a critical component of medical care for patients with chronic kidney failure. With..

HCA Healthcare, Inc. (HCA) Stock Report: Navigating Growth in the Healthcare Sector

HCA Healthcare, Inc. (NYSE: HCA), a giant in the medical care facilities industry, continues to be a focal point for investors seeking opportunities within the healthcare sector. With a market..

Roivant Sciences Ltd. (ROIV) Investor Outlook: Analyzing Its 16.86% Potential Upside

Roivant Sciences Ltd. (NASDAQ: ROIV) is a rising star in the healthcare sector, particularly within the biotechnology industry. Based in London, United Kingdom, this clinical-stage biopharmaceutical company is making waves..

Waystar Holding Corp. (WAY) Stock Analysis: A 47.59% Potential Upside That Investors Shouldn’t Overlook

Waystar Holding Corp. (NASDAQ: WAY) is gaining significant attention from investors, particularly those interested in the healthcare sector’s intersection with technology. Headquartered in Lehi, Utah, Waystar specializes in cloud-based solutions..

Align Technology, Inc. (ALGN) Stock Analysis: Navigating Growth in the Healthcare Sector with a 4.55% Upside

Align Technology, Inc. (NASDAQ: ALGN) stands as a prominent player in the healthcare sector, particularly within the medical instruments and supplies industry. Based in Tempe, Arizona, the company is known..

Teleflex Incorporated (TFX) Stock Analysis: Navigating Growth Amidst a 19.4% Revenue Surge

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is gaining investor attention with its robust 19.4% revenue growth, positioning itself as a compelling option in the medical..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A 43.55% Upside Potential in the Diagnostics & Research Sector

IQVIA Holdings, Inc. (NYSE: IQV) presents a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $28.21..

Masimo Corporation (MASI) Stock Analysis: Navigating Opportunities in a Volatile Market

Masimo Corporation (MASI), a prominent player in the healthcare sector’s medical devices industry, has been capturing investor attention with its diverse portfolio of innovative patient monitoring technologies and automation solutions...

ADMA Biologics Inc (ADMA) Stock Analysis: A Biotech with a 59.42% Potential Upside

ADMA Biologics Inc (NASDAQ: ADMA) presents a compelling opportunity for investors seeking exposure to the biotechnology sector, specifically within the realm of plasma-derived biologics. With a market capitalization of $3.84..

STERIS plc (STE) Investor Outlook: Analyzing a 12.21% Potential Upside with Robust Revenue Growth

STERIS plc (NYSE: STE) stands out in the competitive healthcare sector as a prominent player in the medical devices industry. With a sprawling market capitalization of $24.6 billion, STERIS offers..

GE HealthCare Technologies Inc. (GEHC) Stock Analysis: Exploring a 10.71% Upside Potential

Investors eyeing the healthcare sector might find GE HealthCare Technologies Inc. (NYSE: GEHC) an intriguing player, especially with its potential upside of 10.71%. As a prominent force in the medical..

Revvity, Inc. (RVTY) Stock Analysis: Potential Upside and Strategic Positioning in Diagnostics & Research

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, offers compelling prospects for investors seeking opportunities in the health sciences technology..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Evaluating a 14.55% Potential Upside in the Healthcare Sector

Lantheus Holdings, Inc. (NASDAQ: LNTH), a key player in the healthcare sector, stands out in the specialty and generic drug manufacturing industry. With a market cap of $5.02 billion, Lantheus..

Corcept Therapeutics (CORT): Investor Outlook and Potential 119% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT), a prominent player in the biotechnology sector, has captured the attention of investors with its promising pipeline and robust market position. With a market capitalization..

Qiagen N.V. (QGEN) Stock Analysis: Exploring a 13.71% Upside Potential in the Diagnostics & Research Sector

Qiagen N.V. (NASDAQ: QGEN), a prominent player in the diagnostics and research industry, continues to capture investor attention with its promising market positioning and potential upside. As a leading provider..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds